Table 6.

Clinical and pathological characteristics of the studied cohorts. pT—primary tumor estimation, N—regional lymph nodes, M—distant metastases, R—residual tumor estimation.

Criterion		Cohort-A		Cohort-B
		n	%	n	%
PCa samples		111	100	154	100
Age, years		63 (41–73)	-	62 (46–78)	-
pT	pT3a	55	50	85	55
	pT3b	52	47	65	42
	pT4	4	3	4	3
pN	pN0	73	66	102	66
	pN1	38	34	42	27
cM	cM0	111	100	154	100
	cM1	0	0	0	0
Gleason score	6	15	14	6	4
	7	62	56	59	36
	8	13	12	23	16
	9	20	18	65	43
	10	1	0	1	<1
ISUP	1	15	14	6	4
	2	30	27	28	18
	3	32	28	31	20
	4	13	12	23	15
	5	21	19	66	43
PSA, ng/ml		13.6 (2.5–61)	-	8.7 (2.7–87)	-
Biochemical recurrence (PSA ≥ 0.2 ng/mL)	Yes, N0R0	22	20	15	10
	Yes, N1/R1	6	5	29	19
	No, any N/R	57	51	104	67
	unknown	26	24	6	4
TMPRSS2-ERG molecular subtype	Yes	52	47	76	49
	No	59	53	78	51